35 w - Translate

The Point of Care Molecular Diagnostics market, globally valued at USD 883.5 Million in 2020, is projected to reach USD 2,530.4 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 13.9%. Molecular diagnostics at point of care (POC) have been utilized to enhance the accuracy and specificity of rapid tests conducted near patients, thereby expanding diagnostic capabilities in various healthcare settings such as critical care units, physician offices, and outpatient clinics.